ArticleFrontiers in cardiovascular medicine2024

A comparative study of the clinical benefits of rivaroxaban and dabigatran in patients with nonvalvular atrial fibrillation with high bleeding risk.

Penghui LiuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.